Neonatal Neurology: Clinical Research
Neonatal Neurology 6: Clinical 6
Praveen Kumar, MBBS, DCH, MD
Professor of Clinical Pediatrics
University of Illinois College of Medicine
PEORIA, Illinois, United States
The incidences of any and severe IVH were 22.9% and 9.9%. GA, maternal race, birth location and gender were independent predictors of any IVH (AUC 0.75). Birth weight, Apgar score at 1 minute, birth location and gender were independent predictors of severe IVH (AUC 0.84). For any IVH, 8.7% of infants with score of 1 or less (low risk), 26.5% with score of 2-3 (medium risk) and 56.5% with score of 4 or 5 (high risk) developed any IVH. For severe IVH, a score of 2 or less (low risk) was associated with zero likelihood of severe IVH, score of 3-5 (medium risk) was associated with 7.5% likelihood of severe IVH and a score 6 or more (high risk) had 30% likelihood of severe IVH. Only 62 (14.4%) of all infants were deemed to be at high risk.
A comparison of the performance of any IVH risk scores in derivation and validation cohorts showed that a risk score of 4 or more for any IVH had sensitivities of 30.2% and 30.8%, specificities of 94.1% and 92.7%, positive predictive values of 59.2% and 57.1%, and negative predictive values of 82.6% and 80.9%, respectively. For severe IVH, A risk score of six or more had sensitivities of 50.0% and 60.0%, specificities of 89.1% and 83.3%, positive predictive values of 30.7% and 26.7%, and negative predictive values of 94.8% and 94.8% for derivation and validation cohorts, respectively.
Conclusion(s): This easy to calculate, validated scoring system with a high NPV can help clinicians in employing prevention strategies only for infants at highest risk of IVH and thus, eliminate the risks of these interventions in a large majority of VLBW infants.